Author Archives: Zuzanna Walter

NAMS Releases New Guidelines for Hormone Therapy 

July 21, 2022

The North American Menopause Society (NAMS) recently released its 2022 Guidelines for Hormone Therapy, an update to its 2017 statement that includes significant additions based on the most current scientific evidence. To provide comprehensive and verified guidelines, NAMS recruited an Advisory Panel of experts in the field to review its 2017 Position Statement, evaluate new literature, assess the evidence, and develop updated recommendations.

The 2022 Hormone Therapy Position Statement reflects the latest research findings and recommendations, further clarifies the balance of risks and benefits of hormone therapy, and provides guidance on additional aspects of health care management relevant to patients experiencing menopause symptoms.

Continue reading →

Breakthrough Research Finds Meal Timing Is Key To Longevity

July 15, 2022

Plant-based diets have long been the focal point of longevity research as they have proven to stave off chronic disease, improve biological markers of aging, and aid in weight management, among many other benefits. Current dietary interventions primarily encourage the consumption of plant-based foods and the elimination of processed ingredients. However, emerging research suggests that it is not only the type of food consumed but also the timing of meals that can profoundly affect life- and healthspan. A new study published in the journal Science reveals the promising potential of strategic meal timing to promote anti-aging effects.

Continue reading →

Where Our Worlds Collide: The Systemic Storm of Inflammation, Cardiovascular Disease and Psoriasis 

July 8, 2022

A Partner Blog from Three of the Tarsus Family of Brands: American Academy of Anti-Aging Medicine, Cardiometabolic Health Congress, and LiVDerm.

A review published in May 2021 in the European Cardiology Review sought to elucidate the various potential factors, mechanisms, or processes linking cardiovascular disease (CVD) and psoriasis. Observational relationships between these two diseases include: an increased independent association between cardiovascular disease and severe psoriasis in younger patients; a higher mortality rate in patients with psoriasis with an overall five-year reduction in life expectancy; a parallel rise in psoriasis severity and CVD risk factors such as hypertension, diabetes, hyperlipidemia, and nonalcoholic fatty liver disease; a higher rate of both CVD and psoriasis in geographical populations furthest from the equator; and the majority of deaths in patients with psoriasis being attributed to cardiovascular or cerebrovascular events. The authors of the review noted that severe psoriasis was more strongly linked to cardiovascular-related mortality than was mild or moderate psoriasis.

Continue reading →